Dr. Peter Snyder, Lifespan senior vice president and chief research officer and professor of neurology in the Warren Alpert Medical School, said the agreement advances the goals of the hospitals, the University, and Rhode Island. Lifespan will work with Brown's TVO on many projects and reserves the right to conduct its own IP management on others.
"This terrific collaboration among the largest research institutions in the state will result in greater accomplishments for our scientists," Snyder said. "Not only does this benefit our researchers, but it is a boon to our knowledge-based economy with the promise of more patents and commercial licenses coming out of Rhode Island."
Dennis D. Keefe, Care New England president and COO, said, "There is no doubt that the convergence of the research missions of our hospitals, the Alpert Medical School, and other institutions of higher learning, and private industry could well be the engine for Rhode Island's economic recovery. The possibilities are endless when coupled with the incredible potential of the commercial availability of these discoveries."
Katherine Gordon, TVO managing director, said her team, which includes a new associate director specializing in life sciences, will work to advance the commercial potential of discoveries made by scientists at the University and the hospitals.
"TVO has built up considerable infrastructure and best practices to carry out the often complex variety of tasks needed to turn a novel idea from the lab into commercially viable product," Gordon said. "The office has developed strong relationships with a wide variety of major companies and entrepreneurs who license IP for development into marketable therapies and products, and create jobs. This gives Providence a crit
|Contact: David Orenstein|